Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|December 17, 2019
Evaluation of a change in cytomegalovirus prevention strategy following pediatric solid organ transplantationScott Pangonis, Grant Paulsen, Heidi Andersen, et al.The Pediatric Infectious Disease Journal|April 26, 2021
Novel Treatment of Infant With COVID-19 With the Sialidase Fusion Protein, DAS181Lara Danziger-Isakov, Nadim Khalil, Allison Divanovic, et al.Vaccine|January 11, 2025
Safety and immunogenicity of ascending doses of influenza A(H7N9) inactivated vaccine with or without MF59®Sharon E Frey, Rebecca Brady, Lisa Jackson, et al.Journal of the Pediatric Infectious Diseases Society|March 15, 2018
A Multicenter Consortium to Define the Epidemiology and Outcomes of Pediatric Solid Organ Transplant Recipients With Inpatient Respiratory Virus InfectionLara Danziger-Isakov, William J Steinbach, Grant Paulsen, et al.Blood Advances|February 22, 2024
Immunophenotypic predictors of influenza vaccine immunogenicity in pediatric hematopoietic cell transplant recipientsJustin Z Amarin, Daniel E Dulek, Joshua Simmons, et al.Vaccine|March 19, 2025
A phase I study of the safety, reactogenicity and immunogenicity of two quadrivalent seasonal influenza vaccines (Fluzone® or Flublok®) with or without one of two adjuvants (AF03 or Advax-CpG55.2) in healthy adults 18-45 years of ageTheresa E Hegmann, Emmanuel B Walter, Michael J Smith, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 6, 2023
The Durability of Antibody Responses of Two Doses of High-Dose Relative to Two Doses of Standard-Dose Inactivated Influenza Vaccine in Pediatric Hematopoietic Cell Transplant Recipients: A Multi-Center Randomized Controlled TrialJennifer E Schuster, Lubna Hamdan, Daniel E Dulek, et al.The Journal of Infectious Diseases|September 16, 2024
Immunogenicity and Reactogenicity of High- or Standard-Dose Influenza Vaccine in a Second Consecutive Influenza SeasonHannah Bahakel, Andrew J Spieker, Haya Hayek, et al.Pageof 2